Sarepta Therapeutics | SRPT - ДОЛГ





ДОЛГ Изменить Дата
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amgen USD 54.59B 1.62B 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Capricor Therapeutics USD 3.38M 0 2025-03
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Gilead Sciences USD 24.94B 5M 2025-09
Incyte USD 40.41M 855K 2025-12
Insmed USD 727.89M 163.33M 2025-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Moderna USD 734M 7M 2025-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09